STERIS PLC (NYSE:STE) Updates FY18 Earnings Guidance
STERIS PLC (NYSE:STE) updated its FY18 earnings guidance on Tuesday. The company provided earnings per share guidance of $3.96-4.09 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.04.
Shares of STERIS PLC (STE) traded up 3.75% during midday trading on Tuesday, hitting $85.29. The stock had a trading volume of 317,040 shares. STERIS PLC has a 12 month low of $63.80 and a 12 month high of $87.49. The stock’s 50-day moving average is $82.15 and its 200-day moving average is $74.62. The stock has a market cap of $7.25 billion, a PE ratio of 66.63 and a beta of 1.33.
STERIS PLC (NYSE:STE) last posted its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.80 by $0.05. STERIS PLC had a net margin of 4.20% and a return on equity of 11.12%. The company had revenue of $608 million during the quarter, compared to the consensus estimate of $597.66 million. During the same period last year, the firm earned $0.79 EPS. The company’s revenue for the quarter was down 4.8% on a year-over-year basis. Equities analysts anticipate that STERIS PLC will post $4.04 EPS for the current year.
STE has been the subject of a number of research reports. Zacks Investment Research upgraded shares of STERIS PLC from a hold rating to a buy rating and set a $92.00 price target for the company in a research report on Tuesday, July 11th. Wellington Shields downgraded shares of STERIS PLC from a gradually accumulate rating to a hold rating in a research report on Monday, June 5th. KeyCorp upgraded shares of STERIS PLC from a sector weight rating to an overweight rating and set a $89.00 price target for the company in a research report on Wednesday, May 3rd. Finally, BidaskClub downgraded shares of STERIS PLC from a strong-buy rating to a buy rating in a research report on Monday, July 31st. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The stock has an average rating of Buy and an average price target of $84.00.
In other news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of STERIS PLC stock in a transaction that occurred on Friday, June 2nd. The shares were sold at an average price of $80.05, for a total transaction of $800,500.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Sudhir K. Pahwa sold 800 shares of STERIS PLC stock in a transaction that occurred on Thursday, May 25th. The shares were sold at an average price of $77.28, for a total transaction of $61,824.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 30,340 shares of company stock valued at $2,432,704. Insiders own 2.55% of the company’s stock.
STERIS PLC Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related companies with MarketBeat.com's FREE daily email newsletter.